May 2nd 2024
Study explores how the Inflation Reduction Act’s Drug Price Negotiation Program and its maximum fair prices impact incentives for investments in post-approval activity.
Lessons learned on bona fide service fees and fair market value-is there a 'right answer'?
April 30th 2013Recent regulatory actions and court cases highlight the importance of due diligence in reporting the value of service fees when federal reimbursements are concerned. The financial consequences can be substantial